ADA

Study: Pfizer's Experimental Diabetes Drug Robustly Reduces Weight and Glucose
Study: Pfizer's Experimental Diabetes Drug Robustly Reduces Weight and Glucose
BioSpace
ADA
diabetes
Pfizer
PF-06882961
Flag link:
ADA: Merck, Pfizer's Steglatro rings up CV safety win but still lags heart-helping peers
ADA: Merck, Pfizer's Steglatro rings up CV safety win but still lags heart-helping peers
Fierce Pharma
ADA
diabetes
Merck
Pfizer
Steglatro
Flag link:
ADA: AstraZeneca's diabetes-fighter Farxiga cuts risk of fast decline in kidney function
ADA: AstraZeneca's diabetes-fighter Farxiga cuts risk of fast decline in kidney function
Fierce Pharma
AstraZeneca
Farxiga
chronic kidney disease
ADA
diabetes
Flag link:
Why MannKind Stock Crushed it Monday
Why MannKind Stock Crushed it Monday
Motley Fool
MannKind
ADA
diabetes
insulin
Afrezza
inhaled insulin
Flag link:
ADA: Lilly's Trulicity tops Ozempic at keeping patients compliant, real-world data show
ADA: Lilly's Trulicity tops Ozempic at keeping patients compliant, real-world data show
Fierce Pharma
ADA
diabetes
Eli Lilly
Trulicity
Novo Nordisk
Ozempic
Flag link:
ADA: Sanofi bolsters Soliqua with real-world data showing starting insulin, GLP-1 together helps control blood sugar
ADA: Sanofi bolsters Soliqua with real-world data showing starting insulin, GLP-1 together helps control blood sugar
Fierce Pharma
ADA
diabetes
Sanofi
Soliqua
type 2 diabetes
Flag link:
ADA: Novo Nordisk's long-lasting insulin candidate matches Lantus in phase 2
ADA: Novo Nordisk's long-lasting insulin candidate matches Lantus in phase 2
Fierce Pharma
ADA
diabetes
Novo Nordisk
insulin icodec
Sanofi
Lantus
insulin
Flag link:
Key data on Medtronic's 780G, Insulet's Horizon kick off ADA 2020
Key data on Medtronic's 780G, Insulet's Horizon kick off ADA 2020
Medtech Dive
ADA
diabetes
devices
Medtech
Insulet
Medtronic
780G
Horizon insulin delivery system
Flag link:
Fresh analysis spotlights cardio benefit of J&J's Invokana in diabetes patients without history of CV disease
Fresh analysis spotlights cardio benefit of J&J's Invokana in diabetes patients without history of CV disease
Endpoints
JNJ
Invokana
ADA
diabetes
cardiovascular disease
Flag link:
ADA: Lilly, Boehringer's DPP-4 drug Tradjenta ties generic rival in heart safety study
ADA: Lilly, Boehringer's DPP-4 drug Tradjenta ties generic rival in heart safety study
Fierce Pharma
Eli Lilly
Boehringer Ingelheim
ADA
diabetes
Tradjenta
Flag link:
Sanofi's Soliqua Edges Out Competitors in Blood Sugar Control Trial
Sanofi's Soliqua Edges Out Competitors in Blood Sugar Control Trial
Biopharma Dive
Sanofi
diabetes
ADA
Soliqua
clinical trials
Flag link:
Provention’s Teplizumab Can Delay Onset of Type 1 Diabetes, Trial Results Show
Provention’s Teplizumab Can Delay Onset of Type 1 Diabetes, Trial Results Show
BioSpace
Povention Bio
clinical trials
type 1 diabetes
ADA
immunotherapy
Flag link:
ADA: AstraZeneca's Farxiga scores in kidney outcomes study
ADA: AstraZeneca's Farxiga scores in kidney outcomes study
Fierce Pharma
AstraZeneca
ADA
Farxiga
clinical trials
renal disease
Flag link:
Lilly plans phase 2b NASH trial of dual GIP, GLP-1 agonist
Lilly plans phase 2b NASH trial of dual GIP, GLP-1 agonist
Fierce Biotech
Eli Lilly
NASH
tirzepatide
clinial trials
ADA
type 2 diabetes
Flag link:
ADA: Lilly's Trulicity cuts heart risks by 12%. Is it enough to fend off semaglutide?
ADA: Lilly's Trulicity cuts heart risks by 12%. Is it enough to fend off semaglutide?
Fierce Pharma
Eli Lilly
ADA
diabetes
heart attack
stroke
Trulicity
Novo Nordisk
semaglutide
Flag link:
The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trial Readouts
The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trial Readouts
Yahoo/Benzinga
ADA
Merck
Keytruda
NGM Biopharmaceuticals
NGM313/MK-3655
Corbus Pharmaceuticals
Nektar
Galapagos
Kezar Life Sciences
Kura Oncology
Bluebird Bio
BeiGene
Global Blood Therapeutics
Blueprint Medicines
Regeneron
Arqule
Sunesis
Sutro BioPharma
Incyte
Geron
Forty Seven
Flag link:
Insulin Patch Earns Spot in American Diabetes Association Guidelines for Diabetes Care
Insulin Patch Earns Spot in American Diabetes Association Guidelines for Diabetes Care
Xtalks
diabetes
type 2 diabetes
insulin patch
ADA
Valeritas
V-Go
devices
Flag link:
Diabetes group nods to Vascepa, sending Amarin stock higher
Diabetes group nods to Vascepa, sending Amarin stock higher
Biopharma Dive
ADA
Vascepa
Amarin
diabetes
Flag link:
25 European medtech and life sciences start-ups to watch in 2019
25 European medtech and life sciences start-ups to watch in 2019
Silicon Republic
Europe
devices
startups
ADA
Ava
Aiforia
Bambi Medical
BioBeats
BrainWave Bank
Diaceutics
Dobco Medical Systems
Doctena
Etsimo
Fluidic Analytics
Heartbeat Medical
HealthBeacon
Healthera
Healx
Kite Medical
Medherant
Neurent Medical
Nuritas
Oura
Sword Health
UgenTec
WhiteSwell
Ultromics
Xeltis
Flag link:
Amgen's Repatha Reduces Bad Cholestrol in Type II Diabetes
Amgen's Repatha Reduces Bad Cholestrol in Type II Diabetes
NASDAQ.com
Amgen
Repatha
type 2 diabetes
diabetes
hypercholesterolemia
ADA
Flag link:

Pages